BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28712738)

  • 1. A technology-supported collaboration between a health plan and a community pharmacy to improve blood pressure control.
    Frail CK; Cooper S; Gallagher T; Sarkis J; Topor L; Bruzek RJ
    J Am Pharm Assoc (2003); 2017; 57(5):630-634. PubMed ID: 28712738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric asthma medication therapy management through community pharmacy and primary care collaboration.
    Bradley CL; Luder HR; Beck AF; Bowen R; Heaton PC; Kahn RS; Mansour M; Obszarski S; Frede SM
    J Am Pharm Assoc (2003); 2016; 56(4):455-60. PubMed ID: 27245855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of a medication therapy management collaborative within a pediatric health system.
    Sneed G; Kappeler K; Gilmore T; Kuhn C
    J Am Pharm Assoc (2003); 2018; 58(4S):S114-S119. PubMed ID: 29871801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study.
    Papastergiou J; Tolios P; Li W; Li J
    J Am Pharm Assoc (2003); 2017; 57(5):624-629. PubMed ID: 28689706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacist-led intervention to identify persons with diabetes not on statin therapy.
    Drake ES; Harris DK; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S125-S130. PubMed ID: 30006183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing low health literacy with "Talking Pill Bottles": A pilot study in a community pharmacy setting.
    Lam AY; Nguyen JK; Parks JJ; Morisky DE; Berry DL; Wolpin SE
    J Am Pharm Assoc (2003); 2017; 57(1):20-29.e3. PubMed ID: 27777076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality-driven pharmacy and medication therapy management services.
    Trapskin K; Johnson C; Cory P; Sorum S; Decker C
    J Am Pharm Assoc (2003); 2009; 49(5):642-51. PubMed ID: 19748873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A structured patient identification model for medication therapy management services in a community pharmacy.
    Pagano GM; Groves BK; Kuhn CH; Porter K; Mehta BH
    J Am Pharm Assoc (2003); 2017; 57(5):619-623.e1. PubMed ID: 28733156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Texas pharmacists' opinions about and plans for provision of medication therapy management services.
    Moczygemba LR; Barner JC; Roberson K
    J Am Pharm Assoc (2003); 2008; 48(1):38-45. PubMed ID: 18192129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
    Blake KB; Madhavan SS
    Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing an integrated care management program in community pharmacies: A focus on medication management services.
    Smith MG; Ferreri SP; Brown P; Wines K; Shea CM; Pfeiffenberger TM
    J Am Pharm Assoc (2003); 2017; 57(2):229-235.e1. PubMed ID: 28173993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia.
    Bunting BA; Smith BH; Sutherland SE
    J Am Pharm Assoc (2003); 2008; 48(1):23-31. PubMed ID: 18192127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing primary nonadherence: A collaboration between a community pharmacy and a large pediatric clinic.
    Hackerson ML; Luder HR; Beck AF; Wedig JM; Heaton PC; Frede SM
    J Am Pharm Assoc (2003); 2018; 58(4S):S101-S108.e1. PubMed ID: 29730152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving blood pressure control among renal transplant recipients by integrating electronic health technology and clinical pharmacy services.
    Migliozzi DR; Zullo AR; Collins C; Elsaid KA
    Am J Health Syst Pharm; 2015 Nov; 72(22):1987-92. PubMed ID: 26541954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for community-based medication management services in value-based health plans.
    Smith MA; Spiggle S; McConnell B
    Res Social Adm Pharm; 2017; 13(1):48-62. PubMed ID: 26904962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacy characteristics associated with the provision of medication management services within an integrated care management program.
    Smith MG; Shea CM; Brown P; Wines K; Farley JF; Ferreri SP
    J Am Pharm Assoc (2003); 2017; 57(2):217-221.e1. PubMed ID: 28173992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a pharmacogenomics service in a community pharmacy.
    Ferreri SP; Greco AJ; Michaels NM; O'Connor SK; Chater RW; Viera AJ; Faruki H; McLeod HL; Roederer MW
    J Am Pharm Assoc (2003); 2014; 54(2):172-80. PubMed ID: 24632932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient-centered pharmacy services model of HIV patient care in community pharmacy settings: a theoretical and empirical framework.
    Kibicho J; Owczarzak J
    AIDS Patient Care STDS; 2012 Jan; 26(1):20-8. PubMed ID: 22149903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.